RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recovery
Background: World Health Organization (WHO) has recommended Multidrug Therapy (MDT/WHO) for Hansen’s Disease (HD) since 1982; nevertheless, relapse, antimicrobial resistance, and adverse reactions indicate the need for new therapeutic regimens. We evaluated the efficacy and safety of the new anti-HD...
Saved in:
| Main Authors: | Marco Andrey Cipriani Frade, Gustavo Sartori Albertino, Filipe Rocha Lima, Natália Aparecida de Paula, Fabiana Aparecida Correa Cinto, Fernanda Cruz Perecin, Andrezza Westin, Wilson Marques Junior, Helena Barbosa Lugão |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Brazilian Journal of Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S141386702500042X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An alternative multidrug regimen for multibacillary Hansen’s disease: a case report
by: Nazar Akhverdyan, et al.
Published: (2024-12-01) -
Rheumatological manifestations of hansen's disease
by: Anupam Wakhlu, et al.
Published: (2018-01-01) -
A nine-year clinico-epidemiological study of Histoid Hansen in India
by: Vibhu Mendiratta, et al.
Published: (2011-03-01) -
Social representation of Hansen's disease thirty years after the term 'leprosy' was replaced in Brazil
by: Oliveira Maria Leide Wand-del-Rey de, et al.
Published: (2003-01-01) -
Hansen’s Disease with Pure Nerve Involvement and Perineural Abscess Mistaken for Peripheral Nerve Sheath Tumour
by: Moinuddin Sultan, et al.
Published: (2023-09-01)